Inventor
SCHRUM JASON P
US30 patents
⚠️ This page may combine multiple inventors who share the name “SCHRUM JASON P”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MODERNA THERAPEUTICS INC
13 patentsUS9587003B2Mar 7, 2017
Modified polynucleotides for the production of oncology-related proteins and peptides
MODERNA THERAPEUTICS INC67 citations99
US9572896B2Feb 21, 2017
In vivo production of proteins
MODERNA THERAPEUTICS INC75 citations99
US9334328B2May 10, 2016
Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
MODERNA THERAPEUTICS INC110 citations99
US9254311B2Feb 9, 2016
Modified polynucleotides for the production of proteins
MODERNA THERAPEUTICS INC126 citations99
US9221891B2Dec 29, 2015
In vivo production of proteins
MODERNA THERAPEUTICS INC113 citations99
US9181319B2Nov 10, 2015
Engineered nucleic acids and methods of use thereof
MODERNA THERAPEUTICS INC94 citations99
US9657295B2May 23, 2017
Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
MODERNA THERAPEUTICS INC46 citations98
US9572897B2Feb 21, 2017
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
MODERNA THERAPEUTICS INC65 citations98
US9504734B2Nov 29, 2016
Modified polynucleotides for the production of nuclear proteins
MODERNA THERAPEUTICS INC56 citations98
US9464124B2Oct 11, 2016
Engineered nucleic acids and methods of use thereof
MODERNA THERAPEUTICS INC188 citations98
US9447164B2Sep 20, 2016
Engineered nucleic acids and methods of use thereof
MODERNA THERAPEUTICS INC15 citations92
US9827332B2Nov 28, 2017
Modified polynucleotides for the production of proteins
MODERNA THERAPEUTICS INC7 citations84
US9782462B2Oct 10, 2017
Modified polynucleotides for the production of proteins associated with human disease
MODERNA THERAPEUTICS INC7 citations84
MODERNATX INC
10 patentsUS10772975B2Sep 15, 2020
Modified Polynucleotides for the production of biologics and proteins associated with human disease
MODERNATX INC37 citations98
US10064959B2Sep 4, 2018
Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
MODERNATX INC45 citations98
US9937233B2Apr 10, 2018
Engineered nucleic acids and methods of use thereof
MODERNATX INC12 citations92
US9814760B2Nov 14, 2017
Modified polynucleotides for the production of biologics and proteins associated with human disease
MODERNATX INC15 citations92
US10022425B2Jul 17, 2018
Engineered nucleic acids and methods of use thereof
MODERNATX INC13 citations91
US9828416B2Nov 28, 2017
Modified polynucleotides for the production of secreted proteins
MODERNATX INC3 citations84
US9701965B2Jul 11, 2017
Engineered nucleic acids and methods of use thereof
MODERNATX INC4 citations82
US12357708B2Jul 15, 2025
Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
MODERNATX INC1 citations75
US10751386B2Aug 25, 2020
Engineered nucleic acids and methods of use thereof
MODERNATX INC2 citations72
US12496358B2Dec 16, 2025
Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
MODERNATX INC0 citations62
modeRNA Therapeutics
5 patentsUS8999380B2Apr 7, 2015
Modified polynucleotides for the production of biologics and proteins associated with human disease
modeRNA Therapeutics258 citations98
US8680069B2Mar 25, 2014
Modified polynucleotides for the production of G-CSF
modeRNA Therapeutics180 citations98
US9428535B2Aug 30, 2016
Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
modeRNA Therapeutics113 citations97
US8754062B2Jun 17, 2014
DLIN-KC2-DMA lipid nanoparticle delivery of modified polynucleotides
modeRNA Therapeutics204 citations97
US8664194B2Mar 4, 2014
Method for producing a protein of interest in a primate
modeRNA Therapeutics90 citations97